IPEC-Americas? Updated Significant Change Guide for Bulk Pharmaceutical Excipients

Pharmaceutical Technology Editors;

IPEC-Americas? Updated Significant Change Guide for Bulk Pharmaceutical Excipients

March 2, 2005

By Pharmaceutical Technology Editors

News

Article

Pharmaceutical TechnologyPharmaceutical Technology-03-02-2005

Volume 29

Issue 3

IPEC-Americas has just completed a major update to its significant change guideline to address current issues in the manufacture of excipient ingredients and to assist manufacturers in developing an impurity profile.

External Link - article-150844.pdf

Articles in this issue

March 2005

Packaging Becomes Part of the Prescription

Appraisal of the Laser Diffraction Particle-Sizing Technique

Optimism Taking Over in Pharmaceutical Chemicals

In the Spotlight - March 2005

IPEC-Americas? Updated Significant Change Guide for Bulk Pharmaceutical Excipients

A “Disclosure Defense” in Liability Law

Managing Aseptic Interventions

Validating Automated Systems

Implications of Photostability on the Manufacturing, Packaging, Storage, and Testing of Formulated Pharmaceutical Products

Combination Products Raise Manufacturing Challenges

Related Content

mainz,Rhineland-Palatinate /germany - 16 07 2022: the biontech company building and flags in mainz germany | Image Credit: © Tobias Arhelger - stock.adobe.com

CureVac to Be Acquired by BioNTech in $1.25B Deal to Advance mRNA Cancer Therapies

Christopher Cole

June 12th 2025

Article

The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer immunotherapies.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Darmstadt, Germany - November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. | Image Credit: © Anne Czichos - stock.adobe.com

MilliporeSigma and Simtra Launch Five-Year Agreement for Drug Substance, Drug Manufacturing Services

Patrick Lavery

June 11th 2025

Article

The agreement has been designed to offer a turnkey service to companies seeking faster time to market.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas

May 28th 2024

Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

China’s NMPA Approves Merck KGaA Treatment for Tenosynovial Giant Cell Tumor

Patrick Lavery

June 10th 2025

Article

NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with TGCTs that require systemic treatment.